# Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy

> **NCT01673204** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 276 (estimated)

## Conditions studied

- Diabetic Nephropathy

## Interventions

- **DRUG:** Calcitriol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01673204
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-10
- **Primary completion:** 2014-04
- **Final completion:** —
- **Target enrollment:** 276 (ESTIMATED)
- **Last updated:** 2014-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01673204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01673204, "Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01673204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*